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Abstract
Background: The carotid body paraganglioma (chemodectoma) is a relatively rare neoplasm of
obscure origin. These are usually benign and commonly present as asymptomatic cervical mass.
Patients and methods: Records of 12 patients (9 female and 3 male) with carotid body tumors
treated between 1982 and 2003, treated at our center were retrospectively reviewed. Data on
classification, clinical presentation, and surgical treatment were extracted from the case records.
Surgical complications and treatment outcome were noted and survival was calculated by actuarial
method. The literature on carotid body paraganglioma was reviewed.
Results: The average age of the patients was 52 years (range 30–78 years). Eight of these cases
presented as a large asymptomatic non-tender neck mass, and two each presented with dysphagia,
and hoarseness of voice. As per Shamblin classification seven of tumors were type II and 5 were
types III. In 7 cases subadventitial tumor excision was performed, while in 5 associated resection
of both external and internal carotid arteries was carried out. The artery was repaired by end-to-
end anastomosis in one case, with Dacron graft in one case, and with saphenous vein graft in 3
cases. There was no operative mortality. After a mean follow-up of 6.2 years (range 6 months to
20 years), there were no signs of tumor recurrence in any of the cases.
Conclusions:  Surgical excision is the treatment of choice for carotid body paragangliomas
although radiation therapy is an option for patients who are not ideal candidates for surgery. For
the tumors that are in intimate contact with carotid arteries, the treatment by vascular surgeon is
recommended.
Background
Paraganglioma arising from the carotid body are relatively
rare tumors but constitute majority of head and neck par-
agangliomas (60–70%) [1-6]. The term paraganglia was
first used by Kohn in the early twentieth century and is the
most appropriate nomenclature from an embryologic
standpoint [3-5]. Other terms such as carotid body tumor,
glomus tumor, chemodectomas, and nonchromaffin
tumor are less accurate terms and therefore should be best
avoided [7-13]. The neoplasm present as asymptomatic
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neck mass. We report our experience with surgically
treated carotid body tumors.
Patients and methods
Between 1982 and 2003, 12 patients (9 female and 3
male) with carotid body paraganglioma were surgically
treated at the Institute for Cardiovascular Diseases, Ser-
bian Clinical Centre. Mean age of the patients was 52
years (range 30–78 years). The records of these patients
were retrospectively reviewed for clinical presentation,
diagnostic work-up, surgical treatment, and outcome.
Descriptive data was presented as frequency and percent-
age. Survival was calculated by actuarial method. World
literature on carotid body paraganglioma was reviewed.
The articles were extracted using the key words carotid
body and paraganglioma.
All the patients were followed-up periodically every 6
months for the first year, yearly for next 5 years, thereafter
only select patients were followed. The patients who had
undergone carotid artery repair were followed-up with
yearly duplex scanning; two patients were followed by a
computerized tomography (CT) scan, and one by regular
magnetic resonance (MR) imaging.
Results
Eight cases presented as large non-tender neck masses
located just anterior to the sternocleidomastoid muscle,
two patients presented with dysphagia due to hypoglossal
nerve compression, while two other had hoarseness of
voice. The duplex ultrasonography and selective carotid
angiography were used for diagnosis in the eleven cases,
CT in five, and MR imaging in three cases (Figure 1 and 2).
In one case the diagnosis was established on intraopera-
tive exploration.
Intraoperatively on exploration of the neck seven of the
cases showed a medium size tumor intimately associated
and compressing carotid vessels (Shamblin II), and a large
tumor involving carotid vessels in five cases (Shamblin
III). In 7 cases of Shamblin II carotid body paraganglioma
a subadventitial tumor excision was performed while in
other 5 cases both external and internal carotid arteries
were resected. One of these was repaired by end-to-end
anastomosis, one with interposition of Dacron® graft, and
other 3 were repaired with reversed saphenous vein graft.
The histological examination showed no signs of malig-
nancy in any of the tumors. In two cases transient
hypoglossal nerve palsy was noticed. Another patient had
unexpected postoperative hoarseness of voice due to the
transient vagus nerve palsy. All these three cases subse-
quently recovered. There was no operative mortality. The
patients were followed-up from the 6 months to 20 years
(mean 6.2 year) no local, regional or distant metastasis
was noticed. The actuarial survival was 100%.
Discussion
The carotid body was first described by von Haller in 1743
[14]. It is highly specialized organ located at the common
carotid artery bifurcation. Its feeding vessels run primarily
from the external carotid artery. The function of the
carotid body is related to autonomic control of the respi-
ratory and cardiovascular systems, as well as blood tem-
perature [3,10,12,15-23]. Paraganglioma is a relatively
rare neoplasm occurring in carotid body [1-6].
The carotid body paraganglioma is more common in
women [2-5,20,25-28]. The incidence of bilateral carotid
body lesions is approximately 10%. Most of these lesions
are benign however malignant behavior is often encoun-
tered. For diagnosis of malignant carotid body paraganli-
oma there are no clear histological characteristics that
differentiate it from benign lesions. This diagnosis is
reserved for the tumors with local, regional and distant
metastasis. The rate of malignancy is reported to be 6–
12.5% of all cases [3-5,9,11,29-35]. The 7–9% of the cases
are hereditary [2,4,20,25-28,36]. None of our cases were
bilateral or hereditary.
Carotid body paraganglioma often present as slow grow-
ing, non-tender neck masses located just anterior to the
sternocleidomastoid muscle at the level of the hyoid. The
tumor is mobile in the lateral plane but its mobility is lim-
ited in the cephalocaudal direction [3-5,13-15,21,26,36-
38]. Occasionally the tumor mass may transmit the
carotid pulse or demonstrate a bruit or thrill [39]. Because
of its location in close approximation to carotid vessels
and X-XII cranial nerves, tumors enlargement causes pro-
gressive symptoms such as dysphagia (two of our cases),
odynophagia, hoarseness of voice (two of our cases) or
other cranial nerve deficits [2-5,14,26,27,32,37,40]. The
patients may give a history suggestive of symptoms asso-
ciated with catecholamine production such as fluctuating
hypertension, blushing, obstructive sleep apnea and pal-
pitations [3-5,10,14,15,21-23,37].
Size of the tumor has a great importance not only for its
clinical manifestations but also for treatment. In 1971,
Shamblin introduced a classification system based on
tumors size [41]. They classified small tumors that could
be easily dissected away from the vessels as group I. Group
II (7 of our cases) included paragangliomas of medium
size that were intimately associated and compressed
carotid vessels, but could be separated with careful subad-
ventitial dissection. Group III consisted of (5 of our cases)
tumors that were large and typically encased the carotid
artery requiring partial or complete vessel resection and
replacement. Histologically, carotid body paragangliomaWorld Journal of Surgical Oncology 2005, 3:10 http://www.wjso.com/content/3/1/10
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Selective carotid angiography showed carotid body paraganglioma Figure 1
Selective carotid angiography showed carotid body paraganglioma. The typical separation (''lyre sign") of external and internal 
carotid arteries, are presented.World Journal of Surgical Oncology 2005, 3:10 http://www.wjso.com/content/3/1/10
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Selective carotid angiography showed hypervascularization of the carotid body paraganglioma mostly from the external carotid  artery Figure 2
Selective carotid angiography showed hypervascularization of the carotid body paraganglioma mostly from the external carotid 
artery.World Journal of Surgical Oncology 2005, 3:10 http://www.wjso.com/content/3/1/10
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resemble the normal architecture of the carotid body. The
tumors are highly vascular, and between the many capil-
laries are clusters of cells called Zellballen [41].
The carotid angiography is the most useful diagnostic test
for paragangliomas. The angiography demonstrates
tumor blood supply and widening of the carotid bifurca-
tion by a well-defined tumor blush ("lyre sign"), which is
classic pathognomonic angiographic finding [5,8,37-
39,42,43]. MR and contrast CT are more effective non-
invasive imagining modalities comparing with duplex
ultrasonography, especially for small tumors [3,37-39,42-
45]. Radioimmunodetection of carotid body paragangli-
oma by 111In labeled anti-CEA antibody is also described
in literature [9,46]. The differential diagnosis includes
other tumors in this area, carotid artery aneurysms and
elongation. For this reason using of precutaneous fine-
needle aspiration for preoperative diagnosis of carotid
body paraganglioma, can be very dangerous [47].
Resection of carotid body paraganglioma carries inherent
risks of injury to the cranial nerves, carotid arteries as well
excessive blood loss. Reigner first attempted resection of a
carotid body paraganglioma in 1880, but the patients did
not survive [48]. Maydel was the first to remove a carotid
body paraganglioma successfully in 1886, but the patient
became aphasic and hemiplegics due to internal carotid
artery ligature [49]. In 1903, Scudder performed the first
successful removal of carotid body paraganglioma [50].
The surgical excision with careful subadventitial dissec-
tion is treatment of choice for most carotid body paragan-
gliomas (Shamblin I and II) [2-6,14-18,34,37-40,43]. The
Shamblin III of carotid body paraganglioma requires
resection of the external and/or internal carotid artery. If
the internal carotid is encased in tumor or damaged dur-
ing resection, immediate repair/replacement should be
performed [15,37,39,40,42,43,51,52]. The second prob-
lem during tumor excision is bleeding, which sometimes
can be massive. In such cases clamping of all carotid arter-
ies is useful, with placement of internal carotid shunt
[18,35,37]. Having in mind our experience with surgical
treatment of both carotid body gangliomas as well as
carotid stenosis, we recommend Pruitt-Inahara double
balloon occlusive internal carotid shunt [37]. The place-
ment of this shunt through incision on the common
carotid artery contributes to the adequate bleeding control
from the common and internal carotid arteries, as well as
brain protection. This procedure gave a clean and dry
operative field during tumor removal [3,37]. Some other
articles recommend angiographic embolization preopera-
tively [3,23,37,42,53-55]. The Preoperative embolization
of a carotid body paraganglioma can be performed by eth-
anol or polyvinyl alcohol. The finally result is a complete
devascularization [55]. Earlier the carotid body paragang-
liomas were considered radioresistant [34]. However,
more recent studies indicate good responses to radiation
therapy [11,30]. Most authors recommend radiotherapy
for giant and recurrent carotid body paragangliomas, and
with malignant carotid body paragangliomas metastatic
to the regional lymph nodes [8,33-36].
The modern surgical techniques have reduced the risk of
postoperative stroke in carotid body paraganglioma resec-
tion to less than 5% [37,40,56]. However, the incidence of
cranial nerve injury remains strikingly high, ranging from
20% to 40% [37,38,48,56,57]. In 20% of patients the
neurological deficits is permanent. We found two (18%)
transient hypoglossal, and one transient vagus nerve dam-
age. recurrence after complete resection occurs in approx-
imately 6% of patients [15,37,39,40,42,43,51,52]. In our
study however, there were no recurrences. The patients
with internal carotid artery reconstruction should
undergo duplex scanning periodically to identify graft
stenosis.
Conclusion
Early operative management is warranted to avoid the
possibility of eventual metastasis and progressive local
invasion to the point of inoperability. In case of tumors
intimately contact with carotid arteries, the treatment by
vascular surgeon is recommended.
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